Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.

Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate (cORR) of 52% in serous endometrial cancer (EC) Late-breaking oral presentation and ...

(Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its ...

Scientists at The Rockefeller University have built a prototype mass spectrometer that can process over a billion molecules ...

Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational ...

TORONTO and SAN FRANCISCO, March 17, 2026 /PRNewswire/ - Dalriada Drug Discovery ("Dalriada"), a partnered discovery organization supporting small-molecule programs from hit identification through ...

New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...

Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of the NULISAseq Neuro 220 Panel with ...

Dr Singh highlighted India’s unique advantage in genomic research due to its large and genetically diverse population.

Aditxt Inc. (NASDAQ:ADTX) announced it has acquired Ignite Proteomics LLC, a precision oncology company specializing in functional proteomics technology used to guide cancer treatment decisions, ...

(NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC (“Ignite”), a ...

Autoimmune and autoinflammatory diseases are distinct but related categories of disorders characterized by an abnormal immune response. While autoimmune diseases involve adaptive immunity and the ...